Back to the congress' homepage/Volver al inicio del congreso
CIN2000
Masafumi Fukagawa, M.D., Ph.D.
Division of Nephrology and Clinical Research Center
Tokyo Teishin Hospital
JAPAN
| Go to the paper/Ir a la comunicación |
|
Back to the congress' homepage/Volver al inicio del congreso |
Due to some transcription problems, I wonder whether the PDGF_ mentioned in your text refers to PDGF-beta (known mediator of proliferation and migration of myofibroblastsm, interactions with TGF-beta,... among many other actions) or PDGF-alfa (also related in some reports to vascular damage).
Are you aware of any action of PDF in VASCULAR lesions?
Can you give us more insights on FSP-1 and transdifferentiation?
I am amazed about PDF not only inhibiting but also restoring back tissue fibrosis
Where I wrote PDF , I should have obviously written PFD